Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 25, 2013

View Archived Issues

Covagen and Tanabe Research Laboratories expand research collaboration

Aphios spins off Amylon to develop Alzheimer's disease drug

Phase II results for the DENVax vaccine reported at the ASTMH meeting

Flagship VentureLabs introduces new company, Seres Health

Terumo launches intravenous acetaminophen in Japan

Topina approved for pediatric use in Japan

Biological activity seen with ARRY-382 in first-in-human study

EMD Serono describes protein kinase/P70S6K inhibitor scheduled to enter clinical trials

Novel gene variant identified in children susceptible to severe asthma

Imvamune smallpox vaccine approved by Health Canada

Sanofi and Regeneron report phase III data for sarilumab in rheumatoid arthritis

Drug-resistant cancer regression using a combination of an immunotoxin and patient immune depletion

Scientists at Samumed disclose new Wnt signaling inhibitors

Roche divulges new monoclonal antibodies

Reports of irreversible growth factor receptor inhibitor for treating mutant-harboring cancers

Genentech patents new antibody-drug conjugates for melanoma

Novel monoclonal antibodies presented by the Dana-Farber Cancer Institute

European CHMP recommends approval of Sovaldi

Phase II results for KAE-609 in adults with malaria monoinfections

EMA's CHMP supports approval of Xigduo for type 2 diabetes

Positive CHMP opinion for cetuximab in RAS wild-type metastatic colorectal cancer

Deltyba obtains European CHMP recommendation upon re-examination

FDA approves Nexavar for thyroid cancer

FDA approval of simeprevir for chronic HCV genotype 1

Dimethyl fumarate in Tecfidera qualifies as new active substance in Europe

Canagliflozin approved in the E.U. for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...